Zyvox® (linezolid), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections

被引：0
|
作者：
Brickner, Steven J. [1 ]
Barbachyn, Michael R. [2 ]
Hutchinson, Douglas K. [3 ]
Manninen, Peter R. [4 ]
机构：
[1] Pfizer Inc, Antibacterials Chem, Groton New London Labs, Groton, CT 06340 USA
[2] Pfizer Inc, Dept Chem, Ann Arbor, MI 48105 USA
[3] Abbott Labs, Abbott Pk, IL 60064 USA
[4] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2007年 / 233卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
257-MEDI
引用
收藏
页码：607 / 607
页数：1
相关论文
共 50 条
  • [1] Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections
    Brickner, Steven J.
    Barbachyn, Michael R.
    Hutchinson, Douglas K.
    Manninen, Peter R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (07) : 1981 - 1990
  • [2] Novel antibacterial agents for the treatment of serious Gram-positive infections
    Abbanat, D
    Macielag, M
    Bush, K
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (03) : 379 - 399
  • [3] Linezolid: First of a new drug class for Gram-positive infections
    Atanaskova N.
    Keshamouni V.G.
    Krueger J.S.
    Schwartz J.A.
    Miller F.
    Reddy K.B.
    Drugs & Therapy Perspectives, 2001, 17 (9) : 1 - 6
  • [4] Linezolid - A synthetic oxazolidinone antimicrobial for treatment of serious gram-positive infections
    Cupo-Abbott, J
    Louie, SG
    Rho, JP
    FORMULARY, 2000, 35 (06) : 483 - +
  • [5] Linezolid: a novel oxazolidinone antimicrobial for the treatment of serious Gram-positive infections - Preface
    Reeves, D
    Wilson, P
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 : 1 - 1
  • [6] Linezolid: a new antibiotic for gram-positive infections
    Wilson, P
    HOSPITAL MEDICINE, 2001, 62 (11): : 682 - 686
  • [7] Linezolid - A review of its use in the management of serious Gram-positive infections
    Perry, CM
    Jarvis, B
    DRUGS, 2001, 61 (04) : 525 - 551
  • [8] Linezolid - A pharmacoeconomic review of its use in serious gram-positive infections
    Plosker, GL
    Figgitt, DP
    PHARMACOECONOMICS, 2005, 23 (09) : 945 - 964
  • [9] Emerging therapies for serious gram-positive bacterial infections: A focus on linezolid
    Plouffe, JF
    CLINICAL INFECTIOUS DISEASES, 2000, 31 : S144 - S149
  • [10] Linezolid in the treatment of Gram-positive prosthetic joint infections
    Bassetti, M
    Vitale, F
    Melica, G
    Righi, E
    Di Biagio, A
    Molfetta, L
    Pipino, F
    Cruciani, M
    Bassetti, D
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (03) : 387 - 390
12345